The Division of Hematology and Oncology conducts research and treats all types of adult cancers including solid tumor cancers and hematological (blood) disorders, as well as coagulation disorders and non-cancerous blood diseases. With over 80 faculty members representing a broad range of professional training and expertise, our dedicated team of professionals is committed to cancer care through
- research to better understand and treat cancers;
- state-of-the-art patient care and personalized cancer therapy;
- clinical trials, including Phase I drug development with subsequent Phase II and Phase III testing;
- training future cancer doctors and researchers; and
- cancer chemotherapy, pharmacology, and biological therapy with an emphasis on solid tumors.
We have met strict clinical and scientific requirements, and we are proud to be consistently ranked among the best places for cancer care by U.S. News and World Report. Our clinical faculty sees patients at the Vanderbilt-Ingram Cancer Center (a National Cancer Institute-designated Comprehensive Cancer Center), the Henry-Joyce Cancer Clinic and Clinical Research Center, and the Vanderbilt University Hospital. Our research faculty continues to build on historical strengths while charting the way for new opportunities in prevention and treatment with an emphasis on bringing new treatment therapies from the laboratory to the clinic as quickly and safely as possible.